You are here: Industry Insights > GSK

News List

GSK appoints HSBC's Iain Mackay as CFO pharmatimes
August 08, 2018
GlaxoSmithKline has appointed Iain Mackay as its new Chief Financial Officer (CFO), marking another high-level appointment under new CEO Emma Walmsley. He joins from HSBC, where he has been Group Finance Director for the last 8 years.
GSK announces closure of Bangladesh facilities pharmafile
July 31, 2018
The British multinational GlaxoSmithKline has announced the closure of its facilities in Bangladesh after more than six decades of operation in the densely populated South Asian country.
GSK adjusts FY2018 guidance after encouraging Q2 results pharmaceutical-technology
July 30, 2018
GlaxoSmithKline (GSK) has upgraded its full year (FY) 2018 guidance after recording growth in sales, margins and cash flow in its financial report for the second quarter (Q2) of 2018.
EuroBiotech Report—AstraZeneca cancer trial, GSK attempts R&D turnaround, Sanofi digital investment and more fiercepharma
July 30, 2018
Welcome to the latest edition of our weekly EuroBiotech Report. Our top stories this week center on AstraZeneca seeing its Array-licensed MEK drug fail in another cancer setting....
GSK invests $300m in 23andMe under drug development deal pharmaceutical-technology
July 27, 2018
GlaxoSmithKline (GSK) has formed a multi-year alliance with genetics firm 23andMe to carry out research and development for new medicines and potential cures.
ViiV unveils positive data for two-drug HIV regimens pharmatimes
July 26, 2018
ViiV Healthcare has unveiled positive clinical data for two two-drug HIV regimens ay the 22nd International AIDS conference in Amsterdam, showing long-term efficacy and non-inferiority to a current standard of care.
GSK ups guidance and unveils major restructure pharmatimes
July 26, 2018
GlaxoSmithKline has upped its expectations for the year after a strong performance by its vaccines division in the second quarter and the delay of a potential generic version of Advair in the US.
FDA staff question efficacy of GSK’s Nucala for COPD pharmatimes
July 25, 2018
US regulatory advisors are questioning the effectiveness of GlaxoSmithKline’s biologic Nucala as a treatment for patients experiencing a sudden worsening of chronic obstructive pulmonary disorder (COPD).
GSK considers splitting up pharmatimes
July 24, 2018
GlaxoSmithKline is reportedly considering whether to split its business into a consumer health spin-off and standalone pharmaceutical and vaccines group.
GSK trials Benlysta/rituximab combo for lupus pharmatimes
July 23, 2018
GlaxoSmithKline has kicked off a Phase III trial assessing its lupus drug Benlysta in combination with rituximab in adult patients with the condition.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page